Operating income before deduction of amortization: Centogene NV (CNTG)

The absolute operating profit reflects the growth dynamics of Centogene N.V. (CNTG), where the value of captures the metric level. The laboratories are implementing robotics to modernize sample preparation. Business stability is ensured by the ownership of a massive biobank and relationships with pharma behemoths. Additional resilience is achieved through the sale of digitized genetic data to global research centers, which offsets the impact of cyclical order volatility.

This metric measures the actual cash flow from operating activities, adjusted for depreciation and inflationary distortions, allowing for an assessment of the business's fundamental ability to generate cash. By analyzing the absolute EBITDA volume on the GURU.Markets platform, an investor determines the monetization efficiency of the intellectual capital of the elite bioinformaticians and geneticists who are building the unique rare disease database of Centogene N.V. (CNTG).